DESFERAL VIALS 500MG

intramuscularintravenoussubcutaneous V03AC01(WHO) N'-{5-[Acetyl(hydroxy)amino]pentyl}-N-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N-hydroxysuccinamide 70-51-9Y 2973 DB00746 2867 J06Y7MXW4D D03670 CHEBI:4356 ChEMBL556 DTXSID7022887 Interactive image CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN InChI=1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-​‍​​​​​‍​‍‍‍‍​‍‍5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34)YKey:UBQYURCVBFRUQT-UHFFFAOYSA-N Deferoxamine(DFOA), also known asdesferrioxamineand sold under the brand nameDesferal, is a medication that bindsironandaluminium.It is specifically used iniron overdose,hemochromatosiseither due to multipleblood transfusionsor an underlyinggenetic condition, andaluminium toxicityin people ondialysis.It is used byinjection into a muscle,vein, orunder the skin. Common side effects include pain at the site of injection, diarrhea, vomiting, fever,hearing loss, and eye problems.Severeallergic reactionsincludinganaphylaxisandlow blood pressuremay occur.It is unclear if use duringpregnancyorbreastfeedingis safe for the baby.Deferoxamine is asiderophorefrom the bacteriaStreptomyces pilosus. Deferoxamine was approved for medical use in the United States in 1968.It is on theWorld Health Organization's List of Essential Medicines.